Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
JCO Oncology Practice
|
August 1, 2025
Fortifying the Workforce: A National Survey of Hematology/Oncology Fellowship Program Leaders Regarding Training Fellows for Community-Based Careers
Anthony Iacoviello, Anika Patel, Shubham Agrawal, et al.
Cancers
|
March 28, 2024
A Real-World Study of Patient Characteristics and Clinical Outcomes in <i>EGFR</i> Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice
Hollis Viray, Andrew J Piper-Vallillo, Page Widick, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 8, 2022
Complete pathologic response to short-course neoadjuvant alectinib in mediastinal node positive (N2) ALK rearranged lung cancer
Daniel Sentana-Lledo, Hollis Viray, Andrew J Piper-Vallillo, et al.
BMC Cancer
|
April 3, 2026
Randomized clinical trial of an Acceptance and Commitment Therapy telehealth intervention ('REVITALIZE') to reduce fatigue interference in women with advanced ovarian cancer on PARP inhibitors: study protocol
Joanna J Arch, Hajime Uno, Hanneke Poort, et al.
Nature Communications
|
December 3, 2025
Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial
Panagiotis A Konstantinopoulos, Ningxuan Zhou, Richard T Penson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
JCO Oncology Practice
|
August 1, 2025
Fortifying the Workforce: A National Survey of Hematology/Oncology Fellowship Program Leaders Regarding Training Fellows for Community-Based Careers
Anthony Iacoviello, Anika Patel, Shubham Agrawal, et al.
Cancers
|
March 28, 2024
A Real-World Study of Patient Characteristics and Clinical Outcomes in <i>EGFR</i> Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice
Hollis Viray, Andrew J Piper-Vallillo, Page Widick, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 8, 2022
Complete pathologic response to short-course neoadjuvant alectinib in mediastinal node positive (N2) ALK rearranged lung cancer
Daniel Sentana-Lledo, Hollis Viray, Andrew J Piper-Vallillo, et al.
BMC Cancer
|
April 3, 2026
Randomized clinical trial of an Acceptance and Commitment Therapy telehealth intervention ('REVITALIZE') to reduce fatigue interference in women with advanced ovarian cancer on PARP inhibitors: study protocol
Joanna J Arch, Hajime Uno, Hanneke Poort, et al.
Nature Communications
|
December 3, 2025
Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial
Panagiotis A Konstantinopoulos, Ningxuan Zhou, Richard T Penson, et al.
Page
of 2